“Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma” (2024) Dermatology Practical & Conceptual, 14(4), p. e2024243. doi:10.5826/dpc.1404a243.